Kanso Diagnostics
Kanso Diagnostics
Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
About
Technology stack
detected 2026-07-01No comments yet. Be the first to share your take.
What does Kanso Diagnostics do?
We strive for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Our novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Our proprietary technology offers PCR grade accuracy with rapid home testing conveniency, enabling an end-to-end solution for diagnosis of bacterial and viral infections anywhere and anytime.
How much funding has Kanso Diagnostics raised?
Kanso Diagnostics has raised a total of $2M in funding. The most recent round on record is Seed.
Where is Kanso Diagnostics headquartered?
Kanso Diagnostics is headquartered in Or Yehuda, Israel.
When was Kanso Diagnostics founded?
Kanso Diagnostics was founded in 2021.
What industry does Kanso Diagnostics operate in?
Kanso Diagnostics operates in Healthcare, Diagnostics, Genetics, Pathology, Biomarkers, HealthTech.
How many employees does Kanso Diagnostics have?
Kanso Diagnostics has approximately 7 people on record.